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I M M U N O L O G Y
Immune synapse instructs epigenomic 
and transcriptomic functional reprogramming 
in dendritic cells
Ana Alcaraz-Serna1,2*, Eugenio Bustos-Morán1,2*, Irene Fernández-Delgado1,2*,  
Diego Calzada-Fraile2*, Daniel Torralba2, Ester Marina-Zárate2, Erika Lorenzo-Vivas2, 
Enrique Vázquez2, Juliana Barreto de Alburquerque3, Nora Ruef3, Manuel José Gómez2, 
Fátima Sánchez-Cabo2, Ana Dopazo2, Jens V. Stein3, Almudena Ramiro2, Francisco Sánchez-Madrid1,2,4†
Understanding the fate of dendritic cells (DCs) after productive immune synapses (postsynaptic DCs) with T cells 
during antigen presentation has been largely neglected in favor of deciphering the nuances of T cell activation 
and memory generation. Here, we describe that postsynaptic DCs switch their transcriptomic signature, correlat-
ing with epigenomic changes including DNA accessibility and histone methylation. We focus on the chemokine 
receptor Ccr7 as a proof-of-concept gene that is increased in postsynaptic DCs. Consistent with our epigenomic 
observations, postsynaptic DCs migrate more efficiently toward CCL19 in vitro and display enhanced homing to 
draining lymph nodes in vivo. This work describes a previously unknown DC population whose transcriptomics, 
epigenomics, and migratory capacity change in response to their cognate contact with T cells.
INTRODUCTION
Interactions between naïve T cells and primed antigen-presenting 
cells, mostly dendritic cells (DCs), are the cornerstone of adaptive 
immunity (1). These contacts (“immune synapses”, IS) mainly occur 
in peripheral lymph nodes, where mature DCs travel from infected 
tissues and establish exploratory contacts until found by antigen- 
specific T cell clones, which undergo subsequent activation and am-
plification (2, 3). Most studies have thoroughly analyzed the IS as a 
platform that drives T cell activation, differentiation, and effector 
function (1), but fewer studies have focused on the DC side (4–6). 
During IS formation, DCs rearrange some of the antigen-presenting 
machinery to enhance their function (7, 8). An active exchange of 
information ensues, with DCs communicating antigenic information 
to T cells. In turn, T cells instruct DCs through membrane receptor 
interactions and T cell–derived exosomes that contain genetic in-
formation, mainly microRNAs and mitochondrial DNA (9, 10). Such 
genetic information transferred from T cells primes DCs to boost 
their antiviral capabilities (9). In addition, some studies suggest that 
antigen presentation to CD4+ T cells leads to DC “licensing” and 
priming, enhancing cross-presentation to CD8+ T cells (cross-priming) 
(11). In addition, DCs receive anti-apoptotic and survival signals 
from the T cell through the IS (4). Moreover, the IS locally promotes 
autophagy and mitophagy and reduces cell death (6). DCs can stay 
alive for up to 15 days in the lymph node after productive IS forma-
tion (12). Some cytokines, for example, type I interferon, increase 
the life span of CD8+ DCs, enhancing cross-presentation and 
priming of CD8+ T cells during bacterial responses (13). Overall, 
this evidence suggests that some DCs could become “memory-like” 
innate cells after cognate immune contact, with enhanced ability to 
respond to subsequent immune challenges. Other cells such as mono-
cytes and natural killer cells have been described to confer a non-
specific protection upon direct infection with a specific pathogen 
(14, 15). These cells display epigenomic (14) and metabolic changes 
(16), sustaining the expression of host defense–related genes that 
would enhance potential responses against future infections. In this 
study, we have analyzed the epigenetic and functional changes in-
duced in CD11c+ bone marrow–derived DCs (BMDCs) upon being 
instructed by antigen cognate interaction with T cells.
RESULTS AND DISCUSSION
To assess the transcriptomic changes displayed by postsynaptic DCs, 
BMDCs were incubated with lipopolysaccharide (LPS) and pulsed (psDCs) 
or not (nsDCs) with the ovalbumin (OVA) peptide OVA323–339. Then, cells 
were allowed to conjugate with resting CD4+ OT-II T cells for 24 hours. 
CD11c+ MHCIIhigh DCs were sorted, and their RNA was isolated 
and analyzed by RNA sequencing (RNA-seq). Differential expres-
sion testing revealed 768 genes up-regulated in psDCs compared to 
nsDCs, with a fold increase (log2) of more than 1. On the other hand, 
340 genes were down-regulated, with a fold reduction of below −1 
(log2). Data analysis showed tight clustering among replicates of both 
conditions, confirming the robustness of the transcriptomic signature 
changes observed in both populations (fig. S1, A and B). Within the 
60 most significantly changed genes, some are expressed in nsDCs, 
e.g., Cd40, Isg15, or Ccr7 [this is likely due to LPS maturation (17)]; 
however, their expression increases one to five times (in log2) in 
psDCs (Fig. 1A). To provide a more general overview of the path-
ways modified by productive interaction with T cells, differentially 
expressed genes were analyzed using Ingenuity Pathway Analysis 
(Qiagen) and clusterProfiler. The former approach revealed a clear 
activation of pathways including DC maturation, T helper 1 cell 
differentiation, and actin cytoskeleton reorganization (Fig. 1B). By 
comparing some known biological functions with the fold change 
of their associated genes, we identified some Gene Ontology (GO) 
terms corresponding to the inflammatory response, including response 
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Fig. 1. psDCs enhance the expression of genes related with inflammation, cytokine response, and antiviral immunity. (A) Heatmap showing normalized gene 
expression values for a selection of 60 genes detected as differentially expressed [Benjamini and Hochberg (B-H)–adjusted P value < 0.05; abs(log2FC) > 1]. RNA-seq–
based transcriptomic profile comparison of psDCs versus nsDCs (n = 3). (B) Enriched canonical pathways detected with IPA on the complete set of 1108 differentially 
expressed genes, after filtering with B-H–adjusted P value < 0.05 and abs(z score) > 1. The length of the bars represents enrichment significance [−log10(B-H P value)], and 
the red dashed line indicates the significance threshold. Bar colors represent “z-score” values (predicted activation state of the pathway, IPA); positive values (dark red) 
indicate higher activity in psDCs. Connected black dots represent parameter “ratio,” this is, the fraction of genes associated with any given pathway included in the collection 
of differentially expressed genes. NF-B, nuclear factor B; IL-8, interleukin-8. (C) Enriched biological process GO terms detected with clusterProfiler on the complete 
set of 1108 differentially expressed genes (right side of the circular plot). Only five selected terms are shown (B-H–adjusted P value < 1 × 10−8) and are connected to small 
rectangles representing differentially expressed genes associated to those terms (left side of the circular plot), colored according to the logFC value. (D) IPA network 
connecting functional terms “virus clearance” and “antiviral response” to associated differentially expressed genes. Genes up- or down-regulated in psDCs relative to 
nsDCs are colored in red and blue, respectively. (E) qPCR analysis of the gene expression levels indicated in psDCs versus nsDCs. Pulsed with or without OVA323–339 cognate 
OT-II peptide or LCMV GP61–80 control peptide [n = 7; Kruskal-Wallis test with Dunn’s posttest or one-way analysis of variance (ANOVA) test with Tukey’s posttest; *P < 0.05, 
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to cytokines or innate immune defense, which were globally activated, 
while cell adhesion was mostly repressed (Fig. 1C). A detailed analysis 
of antiviral response and virus clearance ontologies showed that 
many genes that participate in these pathways were also up-regulated 
in psDCs (Fig. 1D). These results indicate that establishment of the 
IS drives DCs toward a more mature, migratory, and inflammatory 
phenotype that serves the cell to better perform its function upon 
successive triggers with different stimuli. To validate the RNA-seq 
results, we performed real-time quantitative polymerase chain reac-
tion (qPCR) of some genes identified in the RNA-seq screening in 
nsDC and psDC samples. psDCs up-regulated genes such as Ccr7, 
Tlr3, Fscn1, Cd40, Isg15, Ifit1, and Cxcl10 but not DCs pulsed with a 
control peptide lymphocytic choriomeningitis virus (LCMV) GP61–80 
which, similar to OVA323–339, also binds H-I-Ab (Fig. 1E) (18). Incu-
bation with OVA323–339, but not with LCMV GP61–80 peptide, leads 
to a productive IS as indicated by CD4+ T cell activation (fig. S2A). 
Moreover, when DCs were pulsed with whole OVA protein, we 
observed the up-regulation of these genes and CD4+ T cell activation 
(fig. S2, A and B). These data confirmed the findings revealed by the 
RNA-seq screening and indicated that the transcriptomic changes 
observed in psDCs are mostly driven by the cognate IS between DC 
and CD4+ T cells, although a minor contribution of antigen pro-
cessing to this effect (19) cannot be totally ruled out.
To assess whether the observed gene expression reprogramming 
of psDCs was specific of CD4 T-IS, the previous strategy was similarly 
applied to psDCs that have been pulsed with the peptide OVA257–264 
and allowed to interact with CD8+ OT-I cells. The same previously 
validated genes (Ccr7, Tlr3, Fscn1, Cd40, Isg15, Ifit1, and Cxcl10) were 
up-regulated in psDC that had undergone an OVA257–264 peptide–
specific IS with CD8+ T cells. In contrast, DCs pulsed with the 
control peptide vaccinia virus (VACV) B8R20–27, which, similar to 
OVA257–264, binds H-2kb, did not show such response (Fig. 2) (20). 
OVA257–264 but not VACV B8R20–27 resulted in a productive synapse 
as indicated by CD8+ T cell state of activation after the IS (fig. S3). 
The fold change of these genes in psDCs was in the same range as 
the one observed for IS with CD4+ T cells (Figs. 1E and 2).
While some genes up-regulated in psDCs were common to those 
observed in DCs treated with T cell–derived extracellular vesicles (EVs) 
(9), some others differ, suggesting that other mechanisms besides EVs 
transmission are involved. It is likely that membrane-bound receptor- 
ligand interactions, for example, CD40-CD40L (21), may be required 
in the context of the intimate membrane-to-membrane juxtaposition 
that occurs during IS formation. In addition, it is interesting that 
bacterially derived LPS triggering directs DCs to better respond to 
viral infections, suggesting that priming against a specific stimulus 
may generate a state of “general alert” that enhances immune pro-
tection against a variety of aggressors.
Next, we assessed whether modifications in the transcriptomic 
signature of psDCs reflect the acquisition of an innate immune 
memory- like phenotype. Changes in the accessibility of chromatin 
of psDCs were evaluated using ATAC-seq (assay for transposase- 
accessible chromatin with high-throughput sequencing). psDCs and 
nsDCs were isolated and treated with transposase 5 (Tn5) to detect 
regions undergoing active chromatin remodeling. This analysis 
revealed that around 25,000 regions were differentially accessible 
when comparing both conditions [false discovery rate (FDR) < 0.05; 
15,062 with an abs(log2FC) > 1] (Fig. 3A). Most of the differential 
peaks were located in intronic or intergenic areas, at distances rang-
ing 1 to 100 kb from transcription starting sites, suggesting a link 
with regulatory regions (fig. S4, A and B).
Fig. 2. Gene expression of psDCs upon CD8+ T cell IS. qPCR analysis of the expression levels of the indicated genes in DCs cocultured with CD8+ OT-I T cells under the 
presence or absence of OVA257–264 cognate OT-I peptide or VACV B8R20–27 control peptide (n = 7; Kruskal-Wallis test and Dunn’s posttest or one-way ANOVA with Tukey’s 
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RNA-seq and ATAC-seq data seem to concur with more than 
1600 differentially accessible sites located near a differentially ex-
pressed gene (Fig. 3B). Also, functional enrichment analyses for all 
the genes associated to differentially accessible sites revealed biological 
processes that were compatible with those associated with the set of 
differentially expressed genes, particularly those related with adaptive 
immunity and cytokine signaling (Fig. 3C). We then verified that 
some up-regulated gene products, such as Cd40, Ccr7, and Fscn1, also 
presented higher chromatin accessibility in psDCs. Conversely, Cenpa, 
a gene that was down-regulated in the psDCs RNA-seq comparison, 
displayed less chromatin accessibility (Fig. 3D). We then undertook 
a larger-scale effort by performing a chromatin immunoprecipitation 
(ChIP)–qPCR analysis of some of the genes of interest. Sheared 
chromatin from isolated psDCs versus nsDCs was immunoprecipitated 
with an anti-H4K3me3 antibody [H4K3me3 is an activating and 
priming histone marker (22)]. qPCR of the open regions showed that 
Ccr7, Fscn1, or Cd40 associated peaks were enriched in psDCs in this 
assay, confirming the correlation between the transcriptomic and 
epigenetic data (Fig. 3E).
These changes in DNA accessibility and the epigenetic marks of 
the psDCs reflect a contact-dependent priming and reprogramming. 
Fig. 3. Epigenomic signature of psDCs is modified upon T cell contact. (A) MA 
plot representing differential accessibility analysis results for ATAC-seq data. Differ-
entially accessible sites (15,062) [with FDR < 0.05 and abs(log2FC) > 1] are symbolized 
as pink dots over a blue cloud that represents the complete consensus set of 
98,731 ATAC-seq sites. X-axis values (“log concentration”) represent logarithmically 
transformed, normalized counts, averaged for all samples, for each site. Y-axis values 
represent log2(fold change) values for ATAC-seq counts in psDCs relative to nsDCs. 
Positive log2FC values indicate higher accessibility in psDCs. (B) Scatterplot relat-
ing log2(fold change) values for ATAC-seq counts and log2(fold change) values 
for RNA-seq counts. Dots represent the association between 1634 differentially 
accessible genomic sites and 632 differentially expressed genes that were located 
at the shortest distance of a differentially accessible site. (C) Enriched biological pro-
cesses GO terms, detected with GREAT, were associated to differentially accessi-
ble site proximal genes. Only the top 12 terms, sorted by significance, are presented. 
(D) Peak representation of the DNA accessibility in psDCs (green) versus nsDCs 
(blue) within regions proximal to locus for the indicated genes. The height of the 
peak represents the counts per million from the ATAC-seq data (n = 2). (E) ChIP-qPCR 
assay of the coimmunoprecipitation H3K4me3 with the promoter regions of the indi-
cated genes. Results are expressed as fold enrichment relative to a glyceraldehyde-
3- phosphate dehydrogenase promoter region (n = 5, paired t test; *P < 0.05).
Fig. 4. IS enhances psDC migratory capacity in response to Ccr7. (A) Transwell 
assay of psDCs and nsDCs in response to CCL19 (100 ng/ml) for 3 hours. Medium 
without cytokines was set as a control (basal). Cell numbers were normalized to the 
initial input of cells (n = 6; Wilcoxon matched-paired signed ranks test; *P < 0.05). 
(B) Image showing the tracks and speed (color coded) of psDCs (green) versus nsDCs 
(red) in an under-agarose assay in response to a CCL19 gradient (focus on the right 
side of the image). (C) Quantification of the speed and straightness of the chemotactic 
movement of DCs in the under-agarose assay (n ≥ 44, Student’s t test; ****P < 0.0001). 
(D) Dot plot describing the gating strategy for the analysis of the number of 
CD11c+ (gated in the CD3− population) and CD45.1+ cells in psDCs and nsDCs. 
(E) Quantification of the number of migrated psDCs and nsDCs in the popliteal 









acional de Investigaciones C
ardiovasculares on Septem
ber 02, 2021
Alcaraz-Serna et al., Sci. Adv. 2021; 7 : eabb9965     3 February 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 8
This priming could reflect an “alert” state. Hence, psDCs could 
activate faster the expression of genes such as Ccr7 or Cd40 against 
future challenges with enhanced subsequent responses.
To functionally validate some of the candidate genes detected in 
the global genome studies, we addressed the migratory capacity of 
psDCs as they display increased levels of Ccr7. Ccr7 belongs to the 
DC gene signature when differentiating with granulocyte-macrophage 
colony-stimulating factor (GM-CSF) and stimulating with LPS (23). 
Moreover, GM-CSF–derived DCs have been described to cluster 
more closely to migratory DCs (24). Thus, to study the migratory 
properties of psDCs, we performed experiments in Boyden-modified 
chambers toward the CCR7 ligand CCL19. We found that psDC 
migrate more efficiently than nsDC (Fig. 4A). Furthermore, psDCs 
migrated faster and more directionally toward CCL19 in under-agarose 
assays. Both parameters together reflect an enhanced chemotactic 
movement of psDCs in response to CCL19 (Fig. 4, B and C, and 
movie S1). To extend these observations to a more physiological 
context, psDCs and nsDCs from CD45.1 mice were injected in the 
footpad of the two limbs of wild-type mice (CD45.2). After 24 hours 
of migration, popliteal, inguinal, and axillary lymph nodes were ex-
tracted, processed, and analyzed by flow cytometry. An increased 
homing of psDCs to the draining lymph node (popliteal) was observed, 
in agreement with an enhanced CCR7-dependent migration (Fig. 4, 
D and E). These results validate the outcome of the RNA-seq and 
ATAC-seq assays at a functional level, indicating that Ccr7 up-regulation 
after a productive synaptic contact could be one of the reasons of the 
improved maturation (25) in addition to more efficient cell migration 
(26). In turn, our data indicate that DCs undergo a transcriptomic, 
epigenomic, and functional reprogramming upon a productive IS. 
Our findings have been described on an IS model using BMDC and 
OT-II or OT-I T cells. We therefore cannot unravel whether other 
factors, not specifically tested in our experimental system, could addi-
tionally influence postsynaptic reprogramming of DC. For instance, 
T cell receptor (TCR) affinity for peptide–major histocompatibility 
complex (pMHC) complexes functionally influences T cells (27, 28). 
In this regard, it would be of interest to determine whether (i) the 
affinity of different TCRs for their cognate pMHC complexes or (ii) 
the heterogeneity of peptide binding affinity to MHC molecules 
could differentially affect the reprogramming of psDCs.
In summary, our data support that during antigen-driven 
interactions, T cells educate DCs, endowing them with enhanced 
capability to fight additional threats. This opens the door to tar-
geting psDC to design novel therapeutic approaches aimed at 




Antibodies and reagents used for flow cytometry were as follows: 
CD11c-BV421 (585452), MHCII-fluorescein isothiocyanate (FITC) 
(553623), 7-aminoactinomycin D (7AAD) (51-68981E), CD69-FITC 
(553236), CD11c-phycoerythrin (PE) (557401), and anti-mouse 
CD16/CD32 (Fc block) (553142) provided by Becton Dickinson 
(BD); CD40-allophycocyanin (APC) (20-8050-U025), CD44-V450 
(75-0441-U025), CD4- PECy7 (60-0041-U100), CD45.1-PerCPCy5 
(65-0453-U500), CD3-FITC (35-0031-U500), CD8-PECy7 (60-0081), 
and Ghost Red 780 Viability Dye (13-0865-T100) from Tonbo 
Biosciences; CD4-FITC (130-109-498), CD62L-PerCP-Vio700 
(130-107-072), CD25-APC (130-109-052), CD4-PerCPCy5.5 (130-
109-497), and CD11c-FITC (130-102-466) provided by Miltenyi; 
CCR7-PE (120105) and TCR- APCCy7 (109220) from BioLegend; and 
AbC RH capture beads (A10389) and LIVE/DEAD Fixable Yellow Dead 
Cell Stain (L34968) from Invitrogen. In addition, cell dyes 5-(and-6)-
(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine (CMTMR) 
(C2927) and carboxyfluorescein diacetate succinimidyl ester (CFSE) 
(C34554) were obtained from Thermo Fisher Scientific, and recom-
binant murine chemokine MIP-3 (CCL19) (250-27B) was provided 
by Peprotech.
Mice
Male C57/BL6 wild-type mice, TCR (V2, V5) transgenic mice 
(OT-II), and TCR (V2, V5) transgenic mice (OT-I), from 8 to 
12 weeks, were housed in the pathogen-free animal facility of the Centro 
Nacional de Investigaciones Cardiovasculares Carlos III (Madrid) 
in accordance with the animal care standards of the institution. Animal 
experiments were approved by the local ethics committee and con-
formed to EU Directive 86/609/EEC and Recommendation 2007/526/EC 
regarding the protection of animals used for experimental and other 
scientific purposes, enforced in Spanish law under Real Decreto 53/2013.
Cell isolation and coculture
All cells were cultured in RPMI 1640, GlutaMAX-I, 25 mM Hepes 
(Gibco-Invitrogen) supplemented with 10% fetal bovine serum 
(FBS), penicillin (50 IU/ml), streptomycin (50 g/ml) (Gibco), and 
-mercaptoethanol (50 M; Sigma-Aldrich). CD4+ or CD8+ T cells 
for coculture were obtained from spleens and lymph nodes of OT-II 
or OT-I mice, respectively, after purification using the CD4+ or 
CD8+ mouse T cell isolation kit from StemCell (19852 and 19853, 
respectively) and biotinylated anti-CD25 antibody (7D4, BD Bio-
sciences). BMDCs were generated from C57/BL6 wild-type mice and 
cultured in the presence of mouse GM-CSF (20 ng/ml). After 3 days, 
cells in suspension were collected and plated with fresh GM-CSF. 
On days 6 and 9, cells were detached with phosphate-buffered saline 
(PBS), EDTA (5 mM), and bovine serum albumin (BSA) (0.5%) and 
plated with fresh medium. Cells were used at days 9 to 10 (80% 
CD11c+) and 24 hours before coculture DCs were matured with LPS 
(250 ng/ml).
Next day, LPS was withdrawn and DCs were pulsed with the cor-
responding peptide (table S1) and cocultured for 24 hours with the 
OT-II purified CD4+ or OT-I purified CD8+ T cells (ratio, 1:2; 
DCs:T cells). For OVA protein processing and antigen presentation, 
DCs were pulsed with Ovalbumin (100 g/ml) (InvivoGen) simul-
taneously with LPS and withdrawn the day after. Alive DCs were then 
sorted either in a Sony Synergy four-laser (4 L) sorter or with an 
ultrapure CD11c+ MicroBeads positive selection kit (Miltenyi).
qPCR and RNA-seq
For qPCR and RNA-seq, RNA from purified nonsynaptic and post-
synaptic DCs was extracted using the RNeasy Micro Kit (Qiagen). 
RNA was quantified using a fluorimeter (Promega), and RNA integrity 
was measured with both an Agilent 6000 Pico Kit and Bioanalyzer. 
For qPCR, 0.5 to 1 g of RNA was retrotrascribed with a Promega 
kit. Then, qPCR was performed with a GoTaq Promega kit and 
SYBR Green using the primers from table S2. For RNA-seq, 200 ng 
of total RNA was used to generate barcoded RNA-seq libraries us-
ing the NEBNext Ultra RNA Library preparation kit (New England 
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DNA 1000 chip, and their concentration was determined using the 
Qubit fluorometer (Life Technologies).
Libraries were sequenced on a HiSeq 2500 (Illumina) to generate 
60 bases of single reads and processed with real time analysis (RTA) 
v1.18.66.3. FastQ files for each sample were obtained using bcl2fastq 
v2.20.0.422 software (Illumina).
ATAC-seq
A number of 5 × 104 synaptic DCs were sorted and lysed [10 mM 
tris-HCl (pH 7.4), 10 mM MgCl2, and 0.1% IGEPAL CA-630] for 
15 min at 4°C while centrifuging at 500g. The supernatant was dis-
card, and nuclei were resuspended in transposase reaction buffer 
with Tn5 and incubated for 1 hour at 37°C and 7 min at 4°C. Later, 
0.1% SDS was added to stop the reaction (5 min, room temperature), 
and DNA was isolated with Agencourt AMPure XP [Beckman Coulter; 
solid phase reversible immobilization (SPRI) beads, 2×] and mea-
sured with Qubit Kit. For DNA library generation, qPCR with i5 
and i7 primers (barcoding) was performed (98°C 2′, 98°C 20ʺ, 63°C 
30ʺ, 72°C 1′, and 4°C ∞; 9 cycles). A size cut-off was conducted 
(0.65× SPRI beads), and DNA was isolated with 1.8× SPRI beads. 
Last, another qPCR was performed with i5 and i7 primers with 6 to 
7 cycles for 0.9 ng/l or with 5 cycles for more than 0.9 ng/l (98°C 
2′, 98°C 20ʺ, 63°C 30ʺ, 72°C 1′, and 4°C ∞), and amplified DNA was 
isolated with SPRI beads (2×), and its concentration was measured 
by Qubit. As control, we used qPCR for Actb promoter (open) and 
Cryaa promoter (closed). An Agilent Pico 6000 bioanalyzer was 
used to assess peak sizes and percentages.
Libraries were sequenced on a HiSeq 2500 (Illumina) to generate 
2 × 100–base pair (bp) reads and processed with RTA v1.18.66.3. 
FastQ files for each sample were obtained using bcl2fastq v2.20.0.422 
software (Illumina). Sequencing reads were trimmed off Illumina 
adapters and transposase sequence using cutadapt 1.16. Then, they 
were aligned to the mouse reference genome (GRCh38 v91) using 
bowtie 1.2.2 with a limit of 2000-bp paired distance. The aligned 
bam files were converted to bw for visualization purposes using 
bamCoverage from deepTools.
Bioinformatics analysis
RNA-seq and ATAC-seq data were analyzed by the Bioinformatics 
Unit of Centro Nacional de Investigaciones Cardiovasculares (CNIC). 
Sequencing reads were preprocessed with a pipeline that used FastQC 
to assess read quality and Cutadapt to trim sequencing reads, elim-
inating Illumina adaptor remains, and to discard reads that were 
shorter than 30 bp. In the case of ATAC-seq, Nextera transposase 
adapter contaminations were also removed with Cutadapt.
Preprocessed RNA-seq reads were mapped against reference tran-
scriptome NCBIM37.65 and quantified using RNA-Seq by expecta-
tion maximization (RSEM). Percentages of reads participating in at 
least one reported alignment were around 85%. Expected expres-
sion counts were then processed with an analysis pipeline using 
Bioconductor package Limma for normalization [trimmed mean 
of M-values (TMM) method] and differential expression testing. 
Only those genes expressed with at least one count per million in a 
number of samples equal to the number of replicate samples of the 
condition with less replicates were taken into account. Gene expres-
sion changes were considered significant if associated to Benjamini 
and Hochberg adjusted P value < 0.05. Given that the number of 
genes detected as differentially expressed was very high (5211 
genes), abs(logFC) > 1 was used as an additional filter to obtain a 
smaller collection of genes for further analyses. The resulting collec-
tion of 1108 genes was then used for functional enrichment analyses 
with Ingenuity Pathway Analysis (IPA) and the R package cluster-
Profiler.
Preprocessed ATAC-seq reads were mapped against reference 
genome mm9 (same assembly than NCBIM37) with a pipeline that 
used the Burrows-Wheeler Aligner-Maximal Exact Match (BWA-
MEM) algorithm as aligner, Piccard to mark duplicate alignments, 
and samtools to eliminate duplicates, chimerics, and suboptimally 
multimapped alignments. Only properly paired and mapped 
reads were kept. Alignments against the mitochondrial genome or 
chromosomes X and Y were also removed. The final number of 
read pairs was 10 to 20 × 106 for any of the samples. Transcription 
start site (TSS) enrichment values, calculated with HOMER’s anno-
tate Peaks function, had values between 4 and 11 for any of the 
samples. Once filtered alignments had been obtained, peaks (acces-
sible DNA regions) were called with MACS2, using parameters 
“--nomodel --shift -100 --extsize 200”, and “-q 0.05” as the FDR 
cut-off. Around 100,000 peaks were detected for any of the sam-
ples. Next, filtered alignments and peaks, in bam and bed formats, 
respectively, were processed with the R package DiffBind to define 
a consensus set of 98,731 peaks, to calculate and normalize their 
coverage in various samples, and to identify differentially acces-
sible regions, using edgeR as analysis method. The fraction of 
reads in peaks (FRiP) score, as calculated by DiffBind, was around 
0.5 for any of the samples. Functional enrichment analyses for the 
set of differentially accessible regions were performed with the 
genomic regions enrichment of annotations tool (GREAT) (29), 
which also provided information about the genes located at the 
shortest distance from any of the regions. Other data manipulations 
and graphical representations (heatmaps, bars, and scatterplots) 
were produced with R.
ChIP-qPCR
ChIP was performed with the iDeal ChIP-seq Kit for Histones 
(Diagenode) following the provider’s instructions. Briefly, isolated 
DCs were fixed with formaldehyde (1%) for 10 min at 37°C, and 
reaction was quenched with cold glycine. Cells were lysed with 
radioimmunoprecipitation assay buffer 20 min at 4°C, and nuclei 
were pelleted at 2300g for 5 min. Later, nuclear lysis buffer was 
applied (130 l), and chromatin was sheared by using a Covaris 
sonicator and the program “Duty 10% PIP” 175 cycles 200 for 15 min. 
Sheared chromatin was incubated with the corresponding anti-histone 
antibody or immunoglobulin G control (1.5 g/ml) conjugated 
with magnetic beads overnight at 4°C. After incubation, beads 
were washed and DNA fragments were eluted and decross-linked 
for 8 hours at 65°C. Last, after fixation reaction was reversed 
(8 hours, 65°C), DNA was isolated with the iPure beads v2 as 
indicated by the manufacturer protocol. qPCR was performed using 
primers against already described promoter regions for the indi-
cated genes (ChIP-seq) as well as against the open regions detected 
for those genes in the ATAC-seq (table S2). Control primers for 
glyceraldehyde-3-phosphate dehydrogenase promoter region were 
used as a positive control.
In vitro migration assay (Transwell)
Postsynaptic DCs were purified after 48 hours of IS formation and re-
suspended in RPMI medium with 0.1% BSA. Cells were settled in 100 l 
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membrane, Costar) over 600 l of RPMI medium with 0.1% BSA 
alone (basal) or containing mouse CCL19 (100 ng/ml). A well was 
filled with the same amount of cells without the membrane as in-
put. Cells were let to migrate for 3 hours at 37°C. Afterward, 
membrane was removed and migrated cells were recovered. Then, 
cells were stained with a viability dye (7AAD) and CD11c+ antibodies 
and analyzed by flow cytometry. The number of migrated cells was 
counted and normalized using Counting Beads (BD).
Under-agarose assay
For this assay, a manufactured microscopy chamber was customed 
from a modified protocol previously described (30). Briefly, a 
17-mm-diameter circle was cut into the center of 60-mm dishes. The 
hole was sealed from the bottom part of the dish using aquarium 
silicone (Marina) and a 24-mm glass coverslip. After the silicone 
dried, we overlaid a 5-mm-high ring cut from a 15-ml Falcon tube 
and sealed the borders with low melting point paraffin. Later, the 
glass was coated for 1 hour at 37°C with 10% FBS in PBS, and a 
1.2% agarose gel (in Hanks’ balanced salt solution/RPMI medium 
supplemented with 10% FBS) was let to polymerize over the glass. 
Nonsynaptic and postsynaptic DCs were stained with CMTMR 
and CFSE (respectively), mixed at a 1:1 ratio (5 × 105 cells globally), 
and plated in a 2-mm-diameter hole performed in the agarose 
gel. In parallel, CCL19 solution (100 ng/ml) was added to another 
2-mm hole. The migration from the original place of the cells toward 
the chemokine was measured with a GE DeltaVision Elite wide-
field fluorescence microscope, taking pictures with a 20× dry ob-
jective (U plan, S Apo, numerical aperture 0.75) every minute for 
2 hours. Images were analyzed with Imaris software (Bitplane).
Homing experiment
After coculture, DCs were purified by CD4+ T cell depletion with a 
CD90.2-positive selection depletion kit (StemCell). Between 5 and 
1 × 106 cells, in RPMI supplemented with 10% FBS were injected in 
the footpad of C57B/L6 wild-type mice (CD45.2). To reduce animal 
variability, nonsynaptic or postsynaptic DCs were injected in dif-
ferent limbs of the same mice. After 24 hours, popliteal, inguinal, and 
axillary lymph nodes were removed and processed with Liberase and 
deoxyribonuclease. Cells were then stained using CD45.1, CD11c, 
CD3, and Ghost Red 780 Viability Dye antibodies and analyzed in a 
BD FACS Canto II cytometer. Total number of cells was normalized 
using Counting Beads (BD).
Statistical analyses
Samples were tested for normality through a Kolmogorov-Smirnov 
normality test. Accordingly, parametric or nonparametric test 
(Student’s t test or Mann-Whitney U test) was applied. Samples with 
more than two groups were analyzed with one-way analysis of vari-
ance (ANOVA) test with Tukey’s posttest for parametric data or 
Kruskal-Wallis with Dunn’s posttest for nonparametric. When work-
ing with dependent samples, a paired t test was conducted. Every 
experiment was analyzed through at least three biological replicates. 
Statistical analysis was performed using GraphPad Prism 6.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/6/eabb9965/DC1
View/request a protocol for this paper from Bio-protocol.
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